| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/28/2002 | WO2002024750A2 Human kidney tumor overexpressed membrane protein 1 |
| 03/28/2002 | WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | WO2002024743A2 55063, a human nmda family member and uses thereof |
| 03/28/2002 | WO2002024742A2 Atp-binding cassette protein |
| 03/28/2002 | WO2002024741A2 Isolated genomic polynucleotide fragments from chromosome 7 |
| 03/28/2002 | WO2002024740A2 Dsp-15 dual-specificity phosphatase |
| 03/28/2002 | WO2002024739A2 Spas-1 cancer antigen |
| 03/28/2002 | WO2002024738A1 β-CATENIN NUCLEAR LOCALIZED PROTEIN |
| 03/28/2002 | WO2002024736A1 Polynucleotides and polypeptides associated with antibiotic biosynthesis and uses therefor |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024730A2 Transduction of dendritic cells using adenoviral vectors |
| 03/28/2002 | WO2002024728A2 Mammalian nuclear receptor cofactor cf6 and methods of use |
| 03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | WO2002024724A1 PREPARATION OF CAPPED mRNA |
| 03/28/2002 | WO2002024723A1 Modified factor viii |
| 03/28/2002 | WO2002024720A1 Antisense modulation of caspase 2 expression |
| 03/28/2002 | WO2002024717A1 Antisense modulation of flip-c expression |
| 03/28/2002 | WO2002024716A2 Nucleotide sequences which code for the tmk gene |
| 03/28/2002 | WO2002024640A2 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
| 03/28/2002 | WO2002024325A2 Acoustic ejection of fluids from a plurality of reservoirs |
| 03/28/2002 | WO2002024234A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 03/28/2002 | WO2002024233A2 Control of nk cell function and survival by modulation of ship activity |
| 03/28/2002 | WO2002024231A1 Use of a nucleic acid/pei complex |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2002024219A1 Growth factor complex |
| 03/28/2002 | WO2002024214A2 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 03/28/2002 | WO2002023983A2 Method of producing non-human mammals |
| 03/28/2002 | WO2002023974A1 Plant having improved tolerance to various environmental stresses, method of constructing the same and polyamine metabolism-relating enzyme gene |
| 03/28/2002 | WO2002004624A9 Novel g protein-coupled receptor protein and dna thereof |
| 03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
| 03/28/2002 | WO2001094952A3 Methods and compositions for modulating oxidized ldl transport |
| 03/28/2002 | WO2001092550A3 Methods and compositions for efficient gene transfer using transcomplementary vectors |
| 03/28/2002 | WO2001091725A3 Biologically useful polyphosphates |
| 03/28/2002 | WO2001089361A3 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 03/28/2002 | WO2001088156A3 33428, a human metalloprotease family member and uses thereof |
| 03/28/2002 | WO2001085966A3 Modification of bacteria |
| 03/28/2002 | WO2001085781A3 Repair of nerve damage |
| 03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001083808A3 Nucleic acid construct system and method utilizing same useful for identifying protein-protein interactions |
| 03/28/2002 | WO2001083692A3 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/28/2002 | WO2001081570A3 Heteromultimeric ion channel receptor and uses thereof |
| 03/28/2002 | WO2001081410A3 G protein-coupled receptors |
| 03/28/2002 | WO2001079497A3 33556, a human transporter and uses thereof |
| 03/28/2002 | WO2001079471A3 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 03/28/2002 | WO2001079459A3 Polypeptides having haloperoxidase activity |
| 03/28/2002 | WO2001079249A3 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them |
| 03/28/2002 | WO2001077347A3 Ketogulonigenium shuttle vectors |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001077150A3 Serine-threonine kinase |
| 03/28/2002 | WO2001075105A3 Human leucine-rich repeat family member and uses thereof |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001073026A3 43238, a novel g protein-coupled receptor and uses therefor |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001070778A3 Maize glycine rich protein promoter and use thereof |
| 03/28/2002 | WO2001070777A3 Leafy cotyledon2 genes and their uses |
| 03/28/2002 | WO2001069247A3 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells |
| 03/28/2002 | WO2001068839A3 Regulation of human lipoxin a4 receptor-like protein |
| 03/28/2002 | WO2001066775A3 Dna joining method |
| 03/28/2002 | WO2001066756A3 22105, a human thioredoxin family member and uses thereof |
| 03/28/2002 | WO2001066751A3 G protein-coupled receptors |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001064958A3 Modified oligonucleotides for mismatch discrimination |
| 03/28/2002 | WO2001064945A3 Novel dna chips |
| 03/28/2002 | WO2001064864A3 Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation |
| 03/28/2002 | WO2001064736A3 Proliferation arrest transcription factor and its use |
| 03/28/2002 | WO2001062925A3 103p2d6: tissue specific protein highly expressed in various cancers |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001061021A3 Transgenic plants having resistance to a fungal disease |
| 03/28/2002 | WO2001057224A3 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001057182A3 Nucleic acids, proteins, and antibodies |
| 03/28/2002 | WO2001055356A3 Human protein kinases and protein kinase-like enzymes |
| 03/28/2002 | WO2001055330A3 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001051606A3 Cell line for preparing and producing ovine adenovirus vectors |
| 03/28/2002 | WO2001049729A3 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 03/28/2002 | WO2001049687A3 Cyclohexene nucleic acids |
| 03/28/2002 | WO2001038552A3 Excipient system that contains coating substances with enzymatically removable side-groups |
| 03/28/2002 | WO2001038512A3 Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (ptgs) |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2001029240A3 Regeneration |
| 03/28/2002 | WO2001027284A9 Recombinant megalomicin biosynthetic genes and uses thereof |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2000070088A3 Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| 03/28/2002 | WO2000063419A9 Combinatorial chemical library supports having indicia at coding positions and methods of use |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000061611A9 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 03/28/2002 | WO2000060051A3 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | US20020038471 Use of VLCFAE for identifying herbicidally active compounds |
| 03/28/2002 | US20020038470 Generating of preferential protein in plants; obtain plant, transform plant, detect plants with preferential protein, propagate and harvest plant |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038468 Expression vector for use in generating animal models which are mutant in pain response |
| 03/28/2002 | US20020038467 Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions |
| 03/28/2002 | US20020038466 Transgenic mice containing magnesium dependent protein phosphatase gene disruptions |
| 03/28/2002 | US20020038465 Non-human animal mutants and methods for production of the same |